Literature DB >> 1611627

Effector molecules from antitumor macrophages induced with OK-432 and cyclophosphamide.

K Ryoyama1.   

Abstract

The present study was designed to determine whether antitumor activity of macrophages induced with OK-432 and cyclophosphamide was mainly dependent on their ability to produce a soluble factor, that is, L-arginine-dependent nitric oxide as measured by nitrite concentration. Nitrite production by peritoneal macrophages from NIH Swiss mice pretreated with OK-432 (125 KE/kg) i.p. twice at 1-week intervals and with cyclophosphamide (200 mg/kg) i.p. 2 days before the second OK-432 treatment, increased with time for 24 h, and proportionally depended on macrophage numbers. Nitrite production was inhibited by actinomycin D and puromycin but not by mitomycin C. NG-Monomethyl-L-arginine, a specific competitive inhibitor of L-arginine-dependent nitric oxide synthesis, also inhibited production. There was a close correlation between nitrite production and antitumor activity in macrophages from mice pretreated with either OK-432 and cyclophosphamide, OK-432, or thioglycolate broth. OK-432 increased both nitrite production and antitumor activities when added to the macrophage from mice pretreated with OK-432 but not with thioglycolate broth. Both activities of macrophages from mice pretreated with OK-432 and cyclophosphamide were enhanced with increasing concentrations of L-arginine (0.125-1 mM) in the culture medium. D-Arginine, however, did not substitute for L-arginine. Neither activity was affected by contact between the macrophage and the EL4 cell. The macrophage showed antitumor activity through a membrane filter though the activity was greatly reduced. This antitumor activity of macrophages through a membrane was also inhibited by NG-Monomethyl-L-arginine, and increased by OK-432. However, conditioned media, obtained by culturing macrophages induced with OK-432 and cyclophosphamide, inhibited growth of EL4 cells. This activity was carried out by dialysable and non-dialysable factors. One of the dialysable factors was nitrite, an oxidized product of nitric oxide. The antitumor activity of non-dialysable factors was heat-stable and production of factors was increased by NG-Monomethyl-L-arginine and OK-432. Also, non-dialysable factors increased both antitumor and nitrite production activities of OK-432-elicited macrophages, when incubated with factors. Such activity of factors was also heat-stable. The production of factors increased with incubation time of macrophages, and was not inhibited by NG-Monomethyl-L-arginine. These results indicate that in vitro antitumor activity of macrophages induced with OK-432 and cyclophosphamide was mainly dependent on L-arginine-dependent nitric oxide, and that macrophage-associated soluble factors other than nitric oxide were also needed to inhibit fully tumor growth in vitro.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1611627     DOI: 10.1007/bf01741048

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN: 0340-7004            Impact factor:   6.968


  26 in total

1.  Regulation of macrophage physiology by L-arginine: role of the oxidative L-arginine deiminase pathway.

Authors:  J E Albina; C D Mills; W L Henry; M D Caldwell
Journal:  J Immunol       Date:  1989-12-01       Impact factor: 5.422

2.  OK-432-mediated augmentation of antitumor immunity and generation of cytotoxic T lymphocytes.

Authors:  T Ujiie
Journal:  Jpn J Exp Med       Date:  1987-04

3.  Induction of nitrite/nitrate synthesis in murine macrophages by BCG infection, lymphokines, or interferon-gamma.

Authors:  D J Stuehr; M A Marletta
Journal:  J Immunol       Date:  1987-07-15       Impact factor: 5.422

4.  Effects of injection routes of growing tumors and PSK or OK-432 on antiproliferative activity of mouse serum.

Authors:  C Ryoyama; K Ryoyama
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

5.  Leishmania major amastigotes initiate the L-arginine-dependent killing mechanism in IFN-gamma-stimulated macrophages by induction of tumor necrosis factor-alpha.

Authors:  S J Green; R M Crawford; J T Hockmeyer; M S Meltzer; C A Nacy
Journal:  J Immunol       Date:  1990-12-15       Impact factor: 5.422

6.  Synthesis of nitric oxide from L-arginine by neutrophils. Release and interaction with superoxide anion.

Authors:  T B McCall; N K Boughton-Smith; R M Palmer; B J Whittle; S Moncada
Journal:  Biochem J       Date:  1989-07-01       Impact factor: 3.857

7.  Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. Comparison of activating cytokines and evidence for independent production.

Authors:  A H Ding; C F Nathan; D J Stuehr
Journal:  J Immunol       Date:  1988-10-01       Impact factor: 5.422

8.  Nitric oxide from L-arginine stimulates the soluble guanylate cyclase in adrenal glands.

Authors:  M Palacios; R G Knowles; R M Palmer; S Moncada
Journal:  Biochem Biophys Res Commun       Date:  1989-12-15       Impact factor: 3.575

9.  Urinary nitrate excretion in relation to murine macrophage activation. Influence of dietary L-arginine and oral NG-monomethyl-L-arginine.

Authors:  D L Granger; J B Hibbs; L M Broadnax
Journal:  J Immunol       Date:  1991-02-15       Impact factor: 5.422

10.  An L-arginine-dependent mechanism mediates Kupffer cell inhibition of hepatocyte protein synthesis in vitro.

Authors:  T R Billiar; R D Curran; D J Stuehr; M A West; B G Bentz; R L Simmons
Journal:  J Exp Med       Date:  1989-04-01       Impact factor: 14.307

View more
  2 in total

1.  Inhibition of macrophage nitric oxide production by arachidonate-cascade inhibitors.

Authors:  K Ryoyama; T Nomura; S Nakamura
Journal:  Cancer Immunol Immunother       Date:  1993-11       Impact factor: 6.968

2.  Ras/myc-transformed serum-free mouse embryo cells under simulated inflammatory and infectious conditions increase levels of nitric oxide and matrix metalloproteinase-9 without a direct association between them.

Authors:  Hideaki Yamaguchi; Yumi Kidachi; Hironori Umetsu; Kazuo Ryoyama
Journal:  Mol Cell Biochem       Date:  2007-07-28       Impact factor: 3.396

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.